Using Clinical Symptoms to Predict Adverse Maternal and Perinatal Outcomes in Women With Preeclampsia: Data From the PIERS (Pre-eclampsia Integrated Estimate of RiSk) Study

Journal of Obstetrics and Gynaecology Canada

Volumn 33, Issue 8, 2011, Pages 803-809

  Yen, Tin Wing ^a   Payne, Beth ^a,b   Qu, Ziguang ^a,b   Hutcheon, Jennifer A ^a,b   Lee, Tang ^a,b   Magee, Laura A ^a,b   Walters, Barry N ^c   von Dadelszen, Peter ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

Preeclampsia; Pregnancy outcome; Signs and symptoms

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; DYSPNEA; EPIGASTRIC PAIN; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PREDICTION; PREDICTIVE VALUE; PREECLAMPSIA; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; SYMPTOM ASSESSMENT; THORAX PAIN; UPPER ABDOMINAL PAIN; VAGINA BLEEDING; VISUAL DISORDER; VOMITING; CLINICAL TRIAL; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

ADULT; COHORT STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84866008553     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34983-0     Document Type: Article

References (11)

1. Steegers E.A.P., von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia. Lancet 2010, 376:631-644.
2. Magee L.A., Helewa M.E., Moutquin J.M. von Dadelszen P; SOGC Hypertension Guideline Committee. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Clinical Practice Guidelines, No. 206, March 2008. J Obstet Gynaecol Can 2008, 30(Suppl 3):S1-S48.
3. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletins, No. 33, January 2002. Obstet Gynecol 2002, 99:159-167.
4. Menzies J., Magee L.A., Macnab Y.C., Ansermino J.M., Li J., Douglas M.J., et al. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy 2007, 26:447-462.
5. Cavkaytar S., Ugurlu E.N., Karaer A., Tapisiz O.L., Danisman N. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome?. Acta Obstet Gynecol Scand 2007, 86:648-651.
6. Martin J.N., May W.L., Magann E.F., Terrone D.A., Rinehart B.K., Blake P.G. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999, 180:1407-1414.
7. von Dadelszen P., Payne B., Menzies J.M., Li J., Ansermino J.M., Broughton Pipkin F., et al. PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011, 377:219-227.
8. Pre-eclampsia Integrated Estimate of RiSk (PIERS). [website] Available at:. Accessed May 30, 2011. https://piers.cfri.ca.
9. Royston P., Altman D.G. Visualizing and assessing discrimination in the logistic regression model. Stat Med 2010 Oct 30, 29(24):2508-2520.
10. Sibai B.M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003, 102:181-192.
11. Adeney K.L., Williams M.A. Migraine headaches and preeclampsia: an epidemiologic review. Headache 2006, 46:794-803.